Tectonic Therapeutic
Signal active
Organization
Contact Information
Overview
Tectonic is a privately held biotechnology company that aims to transform the discovery of novel GPCR-targeted drugs and unlock the therapeutic utility the most challenging receptors in the class. Tectonic’s founders are at the forefront of scientific research in biochemistry and molecular pharmacology with an extensive track record of entrepreneurial achievement.
About
Industries
Biotechnology
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Tectonic Therapeutic headquartered in United States, North America, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $2.5B in funding across 12 round(s). With a team of 11-50 employees, Tectonic Therapeutic is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Tectonic Therapeutic, raised $130.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
7
Lead Investors
0
Total Funding Amount
$210.7M
Details
2
Tectonic Therapeutic has raised a total of $210.7M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | |||
| 2021 | Early Stage Venture | 80.0M |
Investors
Tectonic Therapeutic is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| The Pags Group | - | FUNDING ROUND - The Pags Group | 130.7M |
| Terrance McGuire | - | FUNDING ROUND - Terrance McGuire | 130.7M |
| Tectonic Therapeutic | - | FUNDING ROUND - Tectonic Therapeutic | 130.7M |
| Polaris Partners | - | FUNDING ROUND - Polaris Partners | 130.7M |
Recent Activity
There is no recent news or activity for this profile.